Lifebit

About Lifebit

Lifebit is a precision medicine and genomics company that has developed the world's leading Federated Trusted Research Environment (TRE) platform. The company's technology enables secure, compliant analysis of health data at unprecedented scale—over 275 million patient records—without requiring data to move from its source. This federated approach solves critical challenges in health AI and research where data cannot be centralized due to privacy, sovereignty, or technical constraints. Lifebit's platform suite includes the Trusted Research Environment for turning data into insights, Trusted Data Lakehouse for connecting and cataloging federated data, Trusted Data Hub for querying distributed data as one, and Airlock for secure data governance and export. The company also offers Lifebit R.E.A.L. for real-time drug side effects and disease outbreak surveillance, and specialized solutions for target identification, clinical interpretation, and biomarker discovery. The platform serves multiple sectors including pharmaceutical companies, health systems, government agencies, nonprofits, and data providers. Lifebit's technology has been peer-reviewed and featured in The Lancet Oncology (2025) for enabling federated breast cancer discovery on Genomics England data. The company's approach enables data harmonization, NGS analysis, and OMOP/FHIR standardization across distributed datasets, with customers reporting that processes that normally take years can be completed in minutes. Lifebit's Trusted Data Marketplace provides access to diverse health datasets spanning cardiometabolic, central nervous system, inflammatory, and oncology conditions, supporting clinical trial optimization, patient registries, and translational research at scale.

Clinical Focus

Medical conditions and clinical areas addressed by Lifebit.

Who It Serves

Milestones & Awards

Key Partnerships

Social & Media